Local authorities will receive £16 million in 2020 to 2021 to deliver the preventative HIV treatment.
News
Jardiance bags FDA Fast Track designation
The decision follows a Jardiance Fast Track designation which was granted by the FDA in July 2019 for the risk of cardiovascular death.
Risk of death by stroke down 24%
Stroke is the fourth single leading cause of death in England and Wales.
Pancreas app now available for type I diabetics in UK
The launch is a “major stepping stone” towards providing “widely available, clinically proven, and user friendly artificial pancreas technology to people with type I diabetes.”
Merck, Pfizer terminate Bavencio head and neck cancer trial
The decision follows advice from the trial’s independent data monitoring committee.
COVID-19: Eli Lilly, Elsevier hop on board
Eli Lilly and AbCellera have plans to co-develop antibody products, and Elsevier is set to make all of its research and data content available on PubMed.
£12m committed to preventable disease research
Half of the public aren’t even aware that conditions like type II diabetes may be preventable.
Cediranib trips up in Lynparza combo ovarian cancer trial
When added to Lynparza, the drug didn’t meet the trial’s primary endpoint.
Venclyxto gains approval in Europe
In a trial, the drug in combo with Gazyvaro led to a 65% reduction in the risk of disease worsening or death.
“Two-pronged” DNA repair attack could kill drug-resistant cancers
The new study “establishes the basis for a potentially exciting new approach to treatment.”
Ajovy bags NICE approval
The anti-CGRP preventive therapy is the first of-its-kind to be recommended by NICE.
FDA green lights Opdivo, Yervoy combo for hepatocellular carcinoma
The combo has been granted Accelerated Approval in the US.
Setback for MedDay’s MD1003 as drug fails non-active progressive MS trial
MedDay will review the latest findings in detail “to understand these outcomes to help inform future clinical research in progressive MS and other neurological diseases.”
NICE hits Keytruda with ‘no’ for urothelial cancer
The rejection comes after a review of new evidence collected while the blockbuster was available via the Cancer Drugs Fund.
COVID-19: NHS ‘ramp up’ testing labs as outbreak declared pandemic
As well as testing of people who meet the criteria for being at risk, the NHS and PHE are also carrying out surveillance testing on people in wards and surgeries showing signs of the virus.
